Cleveland Crain’s Article: MCM Capital Partners Sells Dexmet

MCM Capital Partners Sells Portfolio Company Dexmet Corp.

Beachwood private equity firm MCM Capital Partners said it generated an “outstanding” cash-on-cash return of about $8 for every dollar invested in its sale of portfolio company Dexmet Corp.

MCM Capital bought the company in 2006 and sold it, effective Friday, March 1, to private investment firm Sverica International Management LLC, which has locations in Boston and San Francisco. Read Full Article…

Capital ideas,
delivered to your inbox

Recent Posts
View All

Cleveland, OH –MCM Capital Partners (“MCM”), a micro-cap private equity firm based in Cleveland, Ohio, is excited to announce the majority recapitalization of Tech NH, Inc. (“Tech” or the “Company”). Tech, based in Merrimack, New Hampshire, is a technical injection molder serving the medical device, general industrial, defense and green energy industries. Founded in 1982...

As a private equity fund focused on lower middle market manufacturing and distribution businesses, we are often asked about our eventual plans to sell portfolio companies. Private equity investors typically have a planned investment horizon (typically 5-7 years) during which they expect to hold, grow and exit a portfolio company. However, the exact timing of...

Partnering with a private equity fund is sure to have a transformative effect on any business. Gaining clarity on these topics will help determine whether a private equity suitor can be a potential long-term growth partner. 

MCM Capital Partners (“MCM”), a lower middle market private equity fund, is pleased to announce the sale of Performance Plastics (“PPL”), a precision injection molder of highly engineered thermoplastics. PPL doubled revenues and more than doubled EBITDA during our partnership, resulting in an attractive outcome for MCM, its shareholders and the PPL management team. “Over...